National Serum Institute Seeks Drug Regulator's Approval For Market Authorisation Of Its Covid Vaccine As Booster Dose BY PTI
National Drug Regulator's Nod Sought For Phase-3 Study Of Intranasal Covid Vaccine in 5-18 Age Group BY PTI